Scroll Top

Evaluating Market Recovery in Orthopedics

Qsight’s medical device purchasing dataset captures trends in several markets, including the orthopedics market. We took a closer look at top manufactures in the orthopedics segment to figure out which players were contributing to and detracting from overall growth of the market.

  • Orthopedic procedures, largely elective, are more at risk to cancellations during the COVID-19 pandemic, experiencing lows and highs as cases rise and fall.
  • After the initial plummet caused by the first COVID-19 related lockdown almost two years ago, the orthopedic market showed signs of recovery based on Qsight’s healthcare purchasing dataset.
  • When looking at growth within the orthopedics segment between 2019 and 2021, our healthcare facilities purchasing dataset reflected an increase of 3.4% ($16.7B to $17.3B), signaling towards market recovery and growth.
  • Breaking it down by company, Stryker showed the greatest increase in revenue from 2019 to 2021 (+707.1M), while Depuy Synthes (Johnson & Johnson) and Zimmer Biomet experienced the greatest loss ($193.0M and $124.0M respectively).

The above is based on Qsight’s healthcare facilities purchasing dataset, analyzing over $15B in annual spend from the top 9 players in orthopedic medical devices across a panel of 2200+ distinct healthcare facilities and hospitals.

Post Created by Shimul Sheth, Senior Quantitative Analyst, Guidepoint Qsight and Kenny Dolgin, Director of Quantitative Research, Guidepoint Qsight

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.